Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.87 USD | +4.42% | -6.20% | -49.35% |
04-15 | RBC Lowers Price Target on Nevro to $16 From $18, Keeps Sector Perform Rating | MT |
04-11 | Mizuho Adjusts Price Target on Nevro to $16 From $20, Maintains Neutral Rating | MT |
Business Summary
Number of employees: 1,215
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Devices
100.0
%
| 406 | 100.0 % | 425 | 100.0 % | +4.63% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
86.2
%
| 348 | 85.7 % | 367 | 86.2 % | +5.28% |
International
13.8
%
| 58 | 14.3 % | 59 | 13.8 % | +0.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Thornal
CEO | Chief Executive Officer | 50 | 23-04-23 |
D. Grossman
CHM | Chairman | 63 | 19-03-18 |
Roderick MacLeod
DFI | Director of Finance/CFO | 57 | 20-06-14 |
David Caraway
CTO | Chief Tech/Sci/R&D Officer | 67 | 14-03-31 |
Chief Tech/Sci/R&D Officer | 73 | 20-01-19 | |
Chief Tech/Sci/R&D Officer | 54 | 16-06-30 | |
Geeta Kaveti
CMP | Compliance Officer | - | - |
Kerry Bradley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael DeMane
BRD | Director/Board Member | 67 | 11-03-16 |
Angeline McCabe
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael DeMane
BRD | Director/Board Member | 67 | 11-03-16 |
Karen Prange
BRD | Director/Board Member | 60 | 19-12-16 |
D. Grossman
CHM | Chairman | 63 | 19-03-18 |
Director/Board Member | 64 | 19-03-18 | |
Kevin O'Boyle
BRD | Director/Board Member | 68 | 19-03-18 |
Frank Fischer
BRD | Director/Board Member | 82 | 12-09-30 |
Susan Siegel
BRD | Director/Board Member | 63 | 20-12-01 |
Shawn McCormick
BRD | Director/Board Member | 59 | 14-08-31 |
Sridhar Kosaraju
BRD | Director/Board Member | 46 | 21-08-30 |
Kevin Thornal
CEO | Chief Executive Officer | 50 | 23-04-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,364,308 | 35,498,213 ( 95.01 %) | 682,916 ( 1.828 %) | 95.01 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.35% | 382M | |
-4.33% | 184B | |
-2.10% | 107B | |
-4.21% | 67.52B | |
+1.63% | 50.06B | |
+9.89% | 45.67B | |
+3.40% | 41B | |
+3.69% | 26.73B | |
+4.17% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- NVRO Stock
- Company Nevro Corp.